Development and Clinical Evaluation of Bioactive Implant for Interbody Fusion in the Treatment of Degenerative Lumbar Spine Disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F44265786%3A_____%2F12%3A%230000008" target="_blank" >RIV/44265786:_____/12:#0000008 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.intechopen.com/books/low-back-pain-pathogenesis-and-treatment/development-and-clinical-evaluation-of-bioactive-implant-for-interbody-fusion-in-the-treatment-of-de" target="_blank" >http://www.intechopen.com/books/low-back-pain-pathogenesis-and-treatment/development-and-clinical-evaluation-of-bioactive-implant-for-interbody-fusion-in-the-treatment-of-de</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5772/33506" target="_blank" >10.5772/33506</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Development and Clinical Evaluation of Bioactive Implant for Interbody Fusion in the Treatment of Degenerative Lumbar Spine Disease

Popis výsledku v původním jazyce

The work deals with development and clinical evaluation of a new bioactive implant designed for posterior lumbar interbody fusion (PLIF) in surgical treatment of degenerative lumbar spine disease. In the beginning of the nineties of the last century theglassceramic prosthesis BAS-0 made it possible to gain first experiences in materials replacing autografts for PLIF. Its major disadvantage lied in an insufficient resistance in bending, which in clinical setting resulted in some cases in damage of loaded implant. With regard to the mentioned shortcomings we focused on finding more resistant materials featuring bioactive properties. Bioactive titanium with unique surface treatment supplied by the company LASAK proved to be such a type of material. At the end of the last century?s decade a new type of implant for PLIF based on this material was developed. The high resistance of titanium and shape of implant were to ensure primary stability and maintain the height of intervertebral space.

Název v anglickém jazyce

Development and Clinical Evaluation of Bioactive Implant for Interbody Fusion in the Treatment of Degenerative Lumbar Spine Disease

Popis výsledku anglicky

The work deals with development and clinical evaluation of a new bioactive implant designed for posterior lumbar interbody fusion (PLIF) in surgical treatment of degenerative lumbar spine disease. In the beginning of the nineties of the last century theglassceramic prosthesis BAS-0 made it possible to gain first experiences in materials replacing autografts for PLIF. Its major disadvantage lied in an insufficient resistance in bending, which in clinical setting resulted in some cases in damage of loaded implant. With regard to the mentioned shortcomings we focused on finding more resistant materials featuring bioactive properties. Bioactive titanium with unique surface treatment supplied by the company LASAK proved to be such a type of material. At the end of the last century?s decade a new type of implant for PLIF based on this material was developed. The high resistance of titanium and shape of implant were to ensure primary stability and maintain the height of intervertebral space.

Druh

C - Kapitola v odborné knize

CEP obor

FH - Neurologie, neurochirurgie, neurovědy

OECD FORD obor

—

Projekt

<a href="/cs/project/FR-TI3%2F587" target="_blank" >FR-TI3/587: *Výzkum a vývoj biomateriálů a technologií výroby umělých náhrad pro léčbu kostních defektů.</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Low Back Pain Pathogenesis and Treatment

ISBN

978-953-51-0338-7

Počet stran výsledku

20

Strana od-do

201-220

Počet stran knihy

244

Název nakladatele

InTech

Místo vydání

—

Kód UT WoS kapitoly

—